Drug intelligence / Profile preview

cytotoxic T lymphocyte cells

Development stage
Preclinical
Lead developer
Tevogen Bio
Modality
Cell Therapies
Administration
Intravenous, Intratumoral, Intraperitoneal, Intrathecal
01

Overview

Cytotoxic T lymphocyte (CTL) cells are a subtype of immune cell known as CD8+ T cells. They play a central role in the adaptive immune system by directly killing virus-infected, cancerous, or otherwise abnormal host cells. CTLs recognize antigens presented on major histocompatibility complex (MHC) class I molecules via their CD8 receptor and become activated to destroy target cells through the release of cytotoxins such as perforin and granzymes. In immunotherapy research and clinical applications—including cancer therapy—engineered or expanded CTLs may be used to enhance anti-tumor responses[2][4][5]. These therapies can involve genetic modification (e.g., mRNA transfection) to improve their tumor-killing efficacy[4].

Other names
cytotoxic T cellsCTLskiller T cellsCD8+ T cells
02

Targets

MHC I (MHC class I})

Beyond the preview

Go deeper on cytotoxic T lymphocyte cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cytotoxic T lymphocyte cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call